Logo image of DSM

BNYM STRAT MUNI BND (DSM) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:DSM - US09662E1091

5.87 USD
-0.02 (-0.34%)
Last: 11/21/2025, 8:23:52 PM
5.8862 USD
+0.02 (+0.28%)
After Hours: 11/21/2025, 8:23:52 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to DSM. DSM was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of DSM have multiple concerns. DSM has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

DSM had negative earnings in the past year.
DSM had a negative operating cash flow in the past year.
Of the past 5 years DSM 4 years were profitable.
DSM had a positive operating cash flow in 4 of the past 5 years.
DSM Yearly Net Income VS EBIT VS OCF VS FCFDSM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

Industry RankSector Rank
ROA -1.64%
ROE -2.62%
ROIC 2.1%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DSM Yearly ROA, ROE, ROICDSM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 5 -5 -10 -15

1.3 Margins

DSM's Profit Margin has been stable in the last couple of years.
DSM's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of DSM has declined.
Industry RankSector Rank
OM 58.23%
PM (TTM) N/A
GM 61.59%
OM growth 3Y-11.27%
OM growth 5Y-5.57%
PM growth 3Y9.83%
PM growth 5Y-0.03%
GM growth 3Y-10.36%
GM growth 5Y-4.79%
DSM Yearly Profit, Operating, Gross MarginsDSM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 100 -100 -200 -300

2

2. Health

2.1 Basic Checks

The number of shares outstanding for DSM has been reduced compared to 5 years ago.
DSM Yearly Shares OutstandingDSM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2024 10M 20M 30M 40M
DSM Yearly Total Debt VS Total AssetsDSM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.91, we must say that DSM is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.58 indicates that DSM is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Altman-Z 0.91
ROIC/WACCN/A
WACCN/A
DSM Yearly LT Debt VS Equity VS FCFDSM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.53 indicates that DSM should not have too much problems paying its short term obligations.
A Quick Ratio of 1.53 indicates that DSM should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
DSM Yearly Current Assets VS Current LiabilitesDSM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2024 5M 10M 15M

0

3. Growth

3.1 Past

The earnings per share for DSM have decreased strongly by -173.91% in the last year.
DSM shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.01% yearly.
The Revenue has been growing slightly by 4.76% in the past year.
DSM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.34% yearly.
EPS 1Y (TTM)-173.91%
EPS 3Y9.33%
EPS 5Y-4.01%
EPS Q2Q%-431.58%
Revenue 1Y (TTM)4.76%
Revenue growth 3Y-1.1%
Revenue growth 5Y-4.34%
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DSM Yearly Revenue VS EstimatesDSM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024 10M 20M 30M

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DSM. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DSM Price Earnings VS Forward Price EarningsDSM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DSM Per share dataDSM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

DSM has a Yearly Dividend Yield of 3.88%.
DSM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 3.88%

5.2 History

DSM has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
DSM Yearly Dividends per shareDSM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

The earnings of DSM are negative and hence is the payout ratio. DSM will probably not be able to sustain this dividend level.
DP-126.37%
EPS Next 2YN/A
EPS Next 3YN/A
DSM Yearly Income VS Free CF VS DividendDSM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2024 0 20M -20M 40M -40M 60M -60M

BNYM STRAT MUNI BND

NYSE:DSM (11/21/2025, 8:23:52 PM)

After market: 5.8862 +0.02 (+0.28%)

5.87

-0.02 (-0.34%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)02-02 2026-02-02
Inst Owners49.51%
Inst Owner Change3.03%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap290.15M
Revenue(TTM)22.00M
Net Income(TTM)-8.00M
Analysts0
Price TargetN/A
Short Float %0.36%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 3.88%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-126.37%
Div Incr Years0
Div Non Decr Years0
Ex-Date11-14 2025-11-14 (0.023)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.19
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.45
BVpS6.17
TBVpS6.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.64%
ROE -2.62%
ROCE 2.66%
ROIC 2.1%
ROICexc 2.1%
ROICexgc 2.1%
OM 58.23%
PM (TTM) N/A
GM 61.59%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-7.61%
ROICexgc growth 5Y-5.68%
ROICexc growth 3Y-7.61%
ROICexc growth 5Y-5.68%
OM growth 3Y-11.27%
OM growth 5Y-5.57%
PM growth 3Y9.83%
PM growth 5Y-0.03%
GM growth 3Y-10.36%
GM growth 5Y-4.79%
F-Score3
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage -2.94
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 0.91
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-173.91%
EPS 3Y9.33%
EPS 5Y-4.01%
EPS Q2Q%-431.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.76%
Revenue growth 3Y-1.1%
Revenue growth 5Y-4.34%
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.65%
EBIT growth 3Y-12.24%
EBIT growth 5Y-9.68%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-127.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-127.04%
OCF growth 3YN/A
OCF growth 5YN/A

BNYM STRAT MUNI BND / DSM FAQ

What does BNYM STRAT MUNI BND do?

BNY Mellon Strategic Municipal Bond Fund Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. BNY Mellon Strategic Municipal Bond Fund, Inc. (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital. The Fund ordinarily invests all of its net assets in municipal obligations that provide income exempt from federal personal income tax, and has adopted a fundamental investment policy to invest, under normal market conditions, at least 80% of its net assets in municipal obligations. The Fund may purchase floating and variable rate obligations, municipal derivatives, such as custodial receipt programs created by financial intermediaries, tender option bonds, and participations in municipal obligations. The Fund invests in various industries, including transportation, education, medical, airport, water, power, utilities, and multifamily housing. The Fund's investment adviser is BNY Mellon Investment Adviser, Inc.


Can you provide the latest stock price for BNYM STRAT MUNI BND?

The current stock price of DSM is 5.87 USD. The price decreased by -0.34% in the last trading session.


What is the ChartMill technical and fundamental rating of DSM stock?

DSM has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


Which stock exchange lists DSM stock?

DSM stock is listed on the New York Stock Exchange exchange.


Is BNYM STRAT MUNI BND (DSM) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on DSM.